Dr Aysin Tulunay Virlan

  • Research Associate (Immunology & Infection)

telephone: 01413308132
email: Aysin.TulunayVirlan@glasgow.ac.uk

Institute of Infection Immunity, and Inflammation, GBRC Room B428 Level 4, 120 University Place, Glasgow, G12 8TA

ORCID iDhttps://orcid.org/0000-0003-4735-9902

Publications

List by: Type | Date

Jump to: 2022 | 2018 | 2017
Number of items: 5.

2022

Tezcan, N., Özdemir-Kumral, Z. N., Özkan Yenal, N., Çilingir-Kaya, Ö. T., Virlan, A. T. , Özbeyli, D., Çetinel, Ş., Yeğen, B. Ç. and Koç, M. (2022) Nesfatin-1 treatment preserves antioxidant status and attenuates renal fibrosis in rats with unilateral ureteral obstruction. Nephrology Dialysis Transplantation, 37(7), pp. 1238-1248. (doi: 10.1093/ndt/gfac053) (PMID:35218196)

Kelly, L., McGrath, S., Rodgers, L., McCall, K., Tulunay Virlan, A. , Dempsey, F., Crichton, S. and Goodyear, C. S. (2022) Annexin-A1: the culprit or the solution? Immunology, 166(1), pp. 2-16. (doi: 10.1111/imm.13455) (PMID:35146757)

2018

Tom, B. D.M., Symmons, D. and RA-MAP Consortium:, (2018) Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data. RMD Open, 4(2), e000721. (doi: 10.1136/rmdopen-2018-000721) (PMID:30487994) (PMCID:PMC6241979)

Elbasi, M. O., Tulunay Virlan, A. and Eksioglu Demiralp, E. (2018) Killer cell immunoglobulin-like receptor genotypes in the Turkish population. Human Immunology, 79(4), pp. 193-194. (doi: 10.1016/j.humimm.2018.02.008) (PMID:29454072)

2017

Deniz, R., Tulunay-Virlan, A. , Ture Ozdemir, F., Unal, A. U., Ozen, G., Alibaz-Oner, F., Aydin-Tatli, I., Mumcu, G., Ergun, T. and Direskeneli, H. (2017) Th17-inducing conditions lead to in vitro activation of both Th17 and Th1 responses in Behcet’s disease. Immunological Investigations, 46(5), pp. 518-525. (doi: 10.1080/08820139.2017.1306865) (PMID:28414558)

This list was generated on Mon May 29 19:56:54 2023 BST.
Jump to: Articles
Number of items: 5.

Articles

Tezcan, N., Özdemir-Kumral, Z. N., Özkan Yenal, N., Çilingir-Kaya, Ö. T., Virlan, A. T. , Özbeyli, D., Çetinel, Ş., Yeğen, B. Ç. and Koç, M. (2022) Nesfatin-1 treatment preserves antioxidant status and attenuates renal fibrosis in rats with unilateral ureteral obstruction. Nephrology Dialysis Transplantation, 37(7), pp. 1238-1248. (doi: 10.1093/ndt/gfac053) (PMID:35218196)

Kelly, L., McGrath, S., Rodgers, L., McCall, K., Tulunay Virlan, A. , Dempsey, F., Crichton, S. and Goodyear, C. S. (2022) Annexin-A1: the culprit or the solution? Immunology, 166(1), pp. 2-16. (doi: 10.1111/imm.13455) (PMID:35146757)

Tom, B. D.M., Symmons, D. and RA-MAP Consortium:, (2018) Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data. RMD Open, 4(2), e000721. (doi: 10.1136/rmdopen-2018-000721) (PMID:30487994) (PMCID:PMC6241979)

Elbasi, M. O., Tulunay Virlan, A. and Eksioglu Demiralp, E. (2018) Killer cell immunoglobulin-like receptor genotypes in the Turkish population. Human Immunology, 79(4), pp. 193-194. (doi: 10.1016/j.humimm.2018.02.008) (PMID:29454072)

Deniz, R., Tulunay-Virlan, A. , Ture Ozdemir, F., Unal, A. U., Ozen, G., Alibaz-Oner, F., Aydin-Tatli, I., Mumcu, G., Ergun, T. and Direskeneli, H. (2017) Th17-inducing conditions lead to in vitro activation of both Th17 and Th1 responses in Behcet’s disease. Immunological Investigations, 46(5), pp. 518-525. (doi: 10.1080/08820139.2017.1306865) (PMID:28414558)

This list was generated on Mon May 29 19:56:54 2023 BST.